Effects of synbiotic supplementation on cardiometabolic risk factors in overweight or obese calcium oxalate stone formers: a randomized controlled trial.
Targeted microbiome-based supplementation improves multiple heart disease risk factors in overweight patients with kidney stones, expanding intervention research directions.
Synbiotic supplementation improves multiple cardiometabolic risk factors in overweight/obese stone formers in a rigorous double-blind RCT. The dual targeting of microbiome-metabolic axis in a specific high-risk subgroup has potential for broader metabolic intervention research.
What the study was
- Study design
- Double-blind randomized controlled trial
- Population
- Overweight/obese calcium oxalate stone formers with cardiometabolic risk
- Category
- Prevention
- Maturity
- Validated
- Journal
- Scientific reports
Why it surfaced
Double-blind RCT of synbiotic in specific at-risk population; good design quality.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.